Welcome Guest
Home > Clinical Lung Cancer > Volume 3 | Supplement 2

Table of Contents

Volume 3 | Supplement 2

Publication Date: May 2002
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Contributions
Page Number of this Article in the Print Version
S7-S11		 Docetaxel/Platinum in Advanced Non–Small-Cell Lung Cancer: Recent Randomized Trials
Chandra P. Belani, Ryan J. Sauder
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S12-S16		 The Role of Docetaxel in Nonplatinum-Based Combination Chemotherapy for Non–Small-Cell Lung Cancer
W. Jeffrey Petty, Joerg Rathmann, Konstantin H. Dragnev, James R. Rigas
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S17-S22		 The Role of Weekly Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer
John D. Hainsworth
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S23-S28		 Docetaxel in Second-Line Treatment of Non–Small-Cell Lung Cancer
Frank V. Fossella
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S29-S36		 Docetaxel/Radiation Combinations: Rationale and Preclinical Findings
Luka Milas
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S37-S41		 Concurrent Docetaxel and Thoracic Radiation in Non–Small-Cell Lung Cancer
Pasi A. Jänne
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S42-S48		 Concurrent Chemoradiation Strategies in the Management of Unresectable Stage III Non–Small-Cell Lung Cancer
Primo N. Lara, Jr, Zelanna Goldberg, Angela Davies, Derick H.M. Lau, David R. Gandara
  • Abstract
  • No Access
  • Add to Cart